CMTR-CHEMTRAK FDA OK Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CMTR-CHEMTRAK FDA OK

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Miles Rhyne Hoffman, CFA who wrote (138)	12/10/1996 6:54:00 AM
From: Larry Hartman	of 1172

Miles, I own the stock about where you do, but frankly, I dont' agree with you about it being a future tax loss. Company management has bungled things with the start-up of some of their new products, causing delays that have undermined the expectations of this company. With large cap stocks going through the roof, an institutional investor would have been crazy to sit on CMTR these past 6 months or so with delayed sales and the stock dropping so significantly (their selling helping to further that effect). The company has just started going full gear in selling the Cholestrak and H.Pylori products. If there's no significant revenue by CMTR's 1st quarter 1997 then I'd agree with you on the tax write-off. There may be competition, but there's a huge market out there for these products ($200 million per annum predicted for the future HIV Test alone, with 3 other competitors). If CMTR did poorly and only could get revenues up to $40 million (with all of its products) and bring in earnings at $5-10 million, then that would get the price of the stock above where it is now (but the potentialm for the products, imho, is even greater).

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next